Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

In Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains.

Krzyżek P, Franiczek R, Krzyżanowska B, Łaczmański Ł, Migdał P, Gościniak G.

Pathogens. 2019 Nov 10;8(4). pii: E228. doi: 10.3390/pathogens8040228.

2.

Association of select vitamin D receptor gene polymorphisms with the risk of tobacco-related cancers - a meta-analysis.

Laczmanski L, Laczmanska I, Lwow F.

Sci Rep. 2019 Nov 5;9(1):16026. doi: 10.1038/s41598-019-52519-5.

3.

Coexistence of obstructive sleep apnea and telomerase activity, concentration of selected adipose tissue hormones and vascular endothelial function in patients with arterial hypertension.

Martynowicz H, Kornafel-Flak O, Urbanik D, Łaczmański Ł, Sobieszczańska M, Mazur G, Poręba R, Gać P.

Respir Med. 2019 Jul;153:20-25. doi: 10.1016/j.rmed.2019.05.009. Epub 2019 May 17.

PMID:
31136928
4.

The early years of life. Are they influenced by our microbiome?

Jagodzinski A, Zielinska E, Laczmanski L, Hirnle L.

Ginekol Pol. 2019;90(4):228-232. doi: 10.5603/GP.2019.0041.

5.

Blood Circulating miRNAs as Cancer Biomarkers for Diagnosis and Surgical Treatment Response.

Filipów S, Łaczmański Ł.

Front Genet. 2019 Mar 11;10:169. doi: 10.3389/fgene.2019.00169. eCollection 2019. Review.

6.

In Vitro Activity of 3-Bromopyruvate, an Anticancer Compound, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains.

Krzyżek P, Franiczek R, Krzyżanowska B, Łaczmański Ł, Migdał P, Gościniak G.

Cancers (Basel). 2019 Feb 15;11(2). pii: E229. doi: 10.3390/cancers11020229.

7.

Molecular Patterns of Resistance Among Helicobacter pylori Strains in South-Western Poland.

Bińkowska A, Biernat MM, Łaczmański Ł, Gościniak G.

Front Microbiol. 2018 Dec 18;9:3154. doi: 10.3389/fmicb.2018.03154. eCollection 2018.

8.

Skin Autofluorescence, as a Measure of AGE Accumulation in Individuals Suffering from Chronic Plaque Psoriasis.

Kopeć-Pyciarz K, Makulska I, Zwolińska D, Łaczmański Ł, Baran W.

Mediators Inflamm. 2018 Sep 27;2018:4016939. doi: 10.1155/2018/4016939. eCollection 2018.

9.

Exploratory data analysis of a clinical study group: Development of a procedure for exploring multidimensional data.

Konopka BM, Lwow F, Owczarz M, Łaczmański Ł.

PLoS One. 2018 Aug 23;13(8):e0201950. doi: 10.1371/journal.pone.0201950. eCollection 2018.

10.

Assessment of the FTO gene polymorphisms in male patients with metabolic syndrome.

Ślęzak R, Leszczyński P, Warzecha M, Łaczmański Ł, Misiak B.

Adv Clin Exp Med. 2018 Nov;27(11):1581-1585. doi: 10.17219/acem/75676.

11.

Polymorphisms of ABCB1, CYP3A4 and CYP3A5 Genes in Ovarian Cancer and Treatment Response in Poles.

Fiszer-Maliszewska Ł, Łaczmański Ł, Dolińska A, Jagas M, Kołodziejska E, Jankowska M, Kuśnierczyk P.

Anticancer Res. 2018 Mar;38(3):1455-1459.

PMID:
29491071
12.

The Comparison Between Molecular Tumour Profiling in Microdissected and Surgical Tissue Samples.

Laczmanska I, Sasiadek M, Laczmanski L.

Anticancer Res. 2018 Mar;38(3):1415-1418.

PMID:
29491066
13.

Real-Time qPCR as a Method for Detection of Antibody-Neutralized Phage Particles.

Kłopot A, Zakrzewska A, Lecion D, Majewska JM, Harhala MA, Lahutta K, Kaźmierczak Z, Łaczmański Ł, Kłak M, Dąbrowska K.

Front Microbiol. 2017 Nov 6;8:2170. doi: 10.3389/fmicb.2017.02170. eCollection 2017.

14.

Association of the vitamin D receptor FokI gene polymorphism with sex- and non-sex-associated cancers: A meta-analysis.

Laczmanski L, Lwow F, Osina A, Kepska M, Laczmanska I, Witkiewicz W.

Tumour Biol. 2017 Oct;39(10):1010428317727164. doi: 10.1177/1010428317727164.

PMID:
29034815
15.

The PTPN13 Y2081D (T>G) (rs989902) polymorphism is associated with an increased risk of sporadic colorectal cancer.

Laczmanska I, Karpinski P, Gil J, Laczmanski L, Makowska I, Bebenek M, Ramsey D, Sasiadek MM.

Colorectal Dis. 2017 Jul;19(7):O272-O278. doi: 10.1111/codi.13727.

PMID:
28504867
16.

Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: Authors' reply.

Misiak B, Stańczykiewicz B, Łaczmański Ł, Frydecka D.

Schizophr Res. 2018 Feb;192:471-472. doi: 10.1016/j.schres.2017.04.032. Epub 2017 Apr 26. No abstract available.

PMID:
28456468
17.

Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: A systematic review and meta-analysis.

Misiak B, Stańczykiewicz B, Łaczmański Ł, Frydecka D.

Schizophr Res. 2017 Dec;190:18-27. doi: 10.1016/j.schres.2017.03.031. Epub 2017 Mar 20. Review.

PMID:
28325572
18.

Genetic Variation in One-Carbon Metabolism and Changes in Metabolic Parameters in First-Episode Schizophrenia Patients.

Misiak B, Laczmanski L, Sloka NK, Szmida E, Slezak R, Piotrowski P, Kiejna A, Frydecka D.

Int J Neuropsychopharmacol. 2017 Mar 1;20(3):207-212. doi: 10.1093/ijnp/pyw094.

19.

Growth Hormone Treatment Increases Plasma Irisin Concentration in Patients with Turner Syndrome.

Wikiera B, Zawadzka K, Łaczmański Ł, Słoka N, Bolanowski M, Basiak A, Noczyńska A, Daroszewski J.

Horm Metab Res. 2017 Feb;49(2):122-128. doi: 10.1055/s-0042-119788. Epub 2016 Dec 7.

PMID:
27926952
20.

Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism.

Misiak B, Łaczmański Ł, Słoka NK, Szmida E, Piotrowski P, Loska O, Ślęzak R, Kiejna A, Frydecka D.

Psychiatry Res. 2016 Apr 30;238:60-67. doi: 10.1016/j.psychres.2016.01.077. Epub 2016 Feb 10.

PMID:
27086212
21.

Uremic Pruritus Is Not Associated with Endocannabinoid Receptor 1 Gene Polymorphisms.

Heisig M, Łaczmański Ł, Reich A, Lwow F, Szepietowski JC.

Biomed Res Int. 2016;2016:3567527. doi: 10.1155/2016/3567527. Epub 2016 Feb 29.

22.

The Frequencies of Haplotypes of FTO Gene Variants and Their Association with the Distribution of Body Fat in Non-Obese Poles.

Kolačkov K, Łaczmański Ł, Lwow F, Ramsey D, Zdrojowy-Wełna A, Tupikowska M, Bednarek-Tupikowska G.

Adv Clin Exp Med. 2016 Jan-Feb;25(1):33-42. doi: 10.17219/acem/60645.

23.

High PTPRQ Expression and Its Relationship to Expression of PTPRZ1 and the Presence of KRAS Mutations in Colorectal Cancer Tissues.

Laczmanska I, Karpinski P, Gil J, Laczmanski L, Bebenek M, Sasiadek MM.

Anticancer Res. 2016 Feb;36(2):677-81.

PMID:
26851024
24.

Association of serum glypican-4 levels with cardiovascular risk predictors in women with polycystic ovary syndrome - a pilot study.

Jędrzejuk D, Lwow F, Kuliczkowska-Płaksej J, Hirnle L, Trzmiel-Bira A, Lenarcik-Kabza A, Kolackov K, Łaczmański Ł, Milewicz A.

Gynecol Endocrinol. 2016;32(3):223-6. doi: 10.3109/09513590.2015.1110137. Epub 2015 Nov 16.

PMID:
26486309
25.

Classic PCOS phenotype is not associated with deficiency of endogenous vitamin D and VDR gene polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs1544410 (BsmI), rs10735810 (FokI): a case-control study of lower Silesian women.

Jedrzejuk D, Łaczmański Ł, Milewicz A, Kuliczkowska-Płaksej J, Lenarcik-Kabza A, Hirnle L, Zaleska-Dorobisz U, Lwow F.

Gynecol Endocrinol. 2015;31(12):976-9. doi: 10.3109/09513590.2015.1062865. Epub 2015 Sep 30.

PMID:
26422783
26.

Irisin plasma concentration in PCOS and healthy subjects is related to body fat content and android fat distribution.

Pukajło K, Łaczmański Ł, Kolackov K, Kuliczkowska-Płaksej J, Bolanowski M, Milewicz A, Daroszewski J.

Gynecol Endocrinol. 2015;31(11):907-11. doi: 10.3109/09513590.2015.1065482. Epub 2015 Jul 14.

PMID:
26172924
27.

Vitamin D receptor gene polymorphisms in Alzheimer's disease patients.

Łaczmański Ł, Jakubik M, Bednarek-Tupikowska G, Rymaszewska J, Słoka N, Lwow F.

Exp Gerontol. 2015 Sep;69:142-7. doi: 10.1016/j.exger.2015.06.012. Epub 2015 Jun 18.

PMID:
26093050
28.

The relationship between selected VDR, HFE and ALAD gene polymorphisms and several basic toxicological parameters among persons occupationally exposed to lead.

Szymańska-Chabowska A, Łaczmański Ł, Jędrychowska I, Chabowski M, Gać P, Janus A, Gosławska K, Smyk B, Solska U, Mazur G, Poręba R.

Toxicology. 2015 Aug 6;334:12-21. doi: 10.1016/j.tox.2015.05.002. Epub 2015 May 8.

PMID:
25963508
29.

[Irisin--a new mediator of energy homeostasis].

Pukajło K, Kolackov K, Łaczmański Ł, Daroszewski J.

Postepy Hig Med Dosw (Online). 2015 Feb 21;69:233-42. doi: 10.5604/17322693.1141097. Review. Polish.

30.

Association between vitamin D concentration and levels of sex hormones in an elderly Polish population with different genotypes of VDR polymorphisms (rs10735810, rs1544410, rs7975232, rs731236).

Laczmanski L, Lwow F, Mossakowska M, Puzianowska-Kuznicka M, Szwed M, Kolackov K, Krzyzanowska-Swiniarska B, Bar-Andziak E, Chudek J, Sloka N, Milewicz A.

Gene. 2015 Mar 15;559(1):73-6. doi: 10.1016/j.gene.2015.01.022. Epub 2015 Jan 14.

PMID:
25595352
31.

Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism.

Bohdanowicz-Pawlak A, Lenarcik-Kabza A, Brona A, Kuliczkowska-Płaksej J, Łaczmański Ł, Zaleska-Dorobisz U, Milewicz A.

Endokrynol Pol. 2014;65(6):416-21. doi: 10.5603/EP.2014.0058.

32.

Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients.

Misiak B, Frydecka D, Łaczmański Ł, Ślęzak R, Kiejna A.

Eur J Clin Pharmacol. 2014 Dec;70(12):1433-41. doi: 10.1007/s00228-014-1762-2. Epub 2014 Oct 8.

33.

Vitamin D receptor gene polymorphisms in relation to the risk of colorectal cancer in the Polish population.

Laczmanska I, Laczmanski L, Bebenek M, Karpinski P, Czemarmazowicz H, Ramsey D, Milewicz A, Sasiadek MM.

Tumour Biol. 2014 Dec;35(12):12397-401. doi: 10.1007/s13277-014-2554-0. Epub 2014 Sep 7.

34.

Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls.

Kuliczkowska Plaksej J, Laczmanski L, Milewicz A, Lenarcik-Kabza A, Trzmiel-Bira A, Zaleska-Dorobisz U, Lwow F, Hirnle L.

Int J Endocrinol. 2014;2014:232975. doi: 10.1155/2014/232975. Epub 2014 Jul 17.

35.

Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome.

Jędrzejuk D, Laczmański L, Kuliczkowska J, Lenarcik A, Trzmiel-Bira A, Hirnle L, Dorobisz U, Milewicz A, Lwow F, Urbanovych A, Słoka N.

Gynecol Endocrinol. 2015 Jan;31(1):36-9. doi: 10.3109/09513590.2014.946899. Epub 2014 Aug 5.

PMID:
25093427
36.

The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters of women with polycystic ovary syndrome.

Lenarcik-Kabza A, Łaczmański Ł, Milewicz A, Bidzińska-Speichert B, Pawlak M, Kolackov K, Kuliczkowska-Płaksej J, Trzmiel-Bira A, Brona A.

Endokrynol Pol. 2014;65(3):181-8. doi: 10.5603/EP.2014.0025.

PMID:
24971918
37.

Interrelation between genotypes of the vitamin D receptor gene and serum sex hormone concentrations in the Polish elderly population: the PolSenior study.

Laczmanski L, Milewicz A, Puzianowska-Kuznicka M, Lwow F, Kolackov K, Mieszczanowicz U, Pawlak M, Krzyzanowska-Swiniarska B, Bar-Andziak E, Chudek J, Mossakowska M.

Exp Gerontol. 2014 Sep;57:188-90. doi: 10.1016/j.exger.2014.06.007. Epub 2014 Jun 11.

PMID:
24927719
38.

Impact of the PPARGC1A Gly482Ser polymorphism on left ventricular structural and functional abnormalities in patients with hypertension.

Rojek A, Cielecka-Prynda M, Przewlocka-Kosmala M, Laczmanski L, Mysiak A, Kosmala W.

J Hum Hypertens. 2014 Sep;28(9):557-63. doi: 10.1038/jhh.2014.26. Epub 2014 Apr 10.

PMID:
24718382
39.

Polymorphic variants of neurotransmitter receptor genes may affect sexual function in aging males: data from the HALS study.

Jóźków P, Słowińska-Lisowska M, Łaczmański Ł, Mędraś M.

Neuroendocrinology. 2013;98(1):51-9. doi: 10.1159/000350324. Epub 2013 May 30.

40.

Normal exon copy number of the GLI2 and GLI3 genes in patients with esophageal atresia.

Bednarczyk D, Smigiel R, Patkowski D, Laczmanska I, Lebioda A, Laczmanski L, Sasiadek MM.

Dis Esophagus. 2013 Sep-Oct;26(7):678-81. doi: 10.1111/dote.12036. Epub 2013 Feb 26.

PMID:
23442119
41.

Validation of the minisequencing method for detection of G1691A (Leiden) factor V mutation.

Łaczmański Ł, Ślęzak R, Karpiński P, Kolačkov K, Lebioda A, Milewicz A.

Gynecol Endocrinol. 2013 Apr;29(4):319-22. doi: 10.3109/09513590.2012.743003. Epub 2012 Dec 21.

PMID:
23256575
42.

DRD2 C313T and DRD4 48-bp VNTR polymorphisms and physical activity of healthy men in Lower Silesia, Poland (HALS study).

Jozkow P, Slowinska-Lisowska M, Laczmanski L, Medras M.

Ann Hum Biol. 2013 Mar;40(2):186-90. doi: 10.3109/03014460.2012.748829. Epub 2012 Dec 7.

PMID:
23215759
43.

Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.

Karpinski P, Walter M, Szmida E, Ramsey D, Misiak B, Kozlowska J, Bebenek M, Grzebieniak Z, Blin N, Laczmanski L, Sasiadek MM.

Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):201-8. doi: 10.1158/1055-9965.EPI-12-0157. Epub 2012 Nov 21.

44.

Vitamin D receptor gene polymorphism and cardiovascular risk variables in elderly Polish subjects.

Laczmanski L, Milewicz A, Lwow F, Puzianowska-Kuznicka M, Pawlak M, Kolackov K, Jedrzejuk D, Krzyzanowska-Swiniarska B, Bar-Andziak E, Chudek J, Mossakowska M.

Gynecol Endocrinol. 2013 Mar;29(3):268-72. doi: 10.3109/09513590.2012.736562. Epub 2012 Nov 23.

PMID:
23173643
45.

ADRB3 and PPARγ2 gene polymorphisms and their association with cardiovascular disease risk in postmenopausal women.

Lwow F, Dunajska K, Milewicz A, Laczmański L, Jedrzejuk D, Trzmiel-Bira A, Szmigiero L.

Climacteric. 2013 Aug;16(4):473-8. doi: 10.3109/13697137.2012.738721. Epub 2012 Nov 1.

PMID:
23113754
46.

[Multiplex Ligation - dependent Probe Amplification (MLPA) as a screening test in children with developmental defects and intellectual disability of unknown etiology].

Laczmańska I, Jakubiak A, Slęzak R, Pesz K, Stembalska A, Laczmański L, Sąsiadek MM, Smigiel R.

Med Wieku Rozwoj. 2011 Apr-Jun;15(2):132-9. Polish.

47.

[The role of 1691G>A (Leiden) mutation in Factor V gene, 20210G>A in prothrombin gene and 677C>T in MTHFR gene in etiology of early pregnancy loss].

Slezak R, Łaczmański Ł, Karpiński P, Reszczyńska-Slezak D.

Ginekol Pol. 2011 Jun;82(6):446-50. Polish.

PMID:
21853935
48.

Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women.

Łaczmański Ł, Milewicz A, Dunajska K, Jędrzejczuk D, Pawlak M, Lwow F.

Gynecol Endocrinol. 2011 Dec;27(12):1023-7. doi: 10.3109/09513590.2011.569796. Epub 2011 Apr 11.

PMID:
21480765
49.

Melanocortin-4 receptor gene polymorphism and the level of physical activity in men (HALS Study).

Jóźków P, Słowińska-Lisowska M, Łaczmański Ł, Jakubiec D, Mędraś M.

Endocrine. 2011 Feb;39(1):62-8. doi: 10.1007/s12020-010-9412-7. Epub 2010 Nov 3.

PMID:
21046283
50.

Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women?

Milewicz A, Tworowska-Bardzińska U, Jędrzejuk D, Lwow F, Dunajska K, Łaczmański Ł, Pawlak M.

Int J Obes (Lond). 2011 Mar;35(3):373-7. doi: 10.1038/ijo.2010.145. Epub 2010 Sep 14.

PMID:
20838400

Supplemental Content

Loading ...
Support Center